CareLit · DOI-Nachweis · Pneumologie
Tiotropium Plus Olodaterol Fixed-Dose Combination Therapy Provides Lung Function Benefits When Compared With Tiotropium Alone, Irrespective Of Prior Treatment With A Long-Acting Bronchodilator: Post Hoc Analyses Of Two 1-Year-Studies
DOI 10.1055/s-0036-1572054
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Greulich, R Buhl, R Abrahams, L Grönke, L Korducki, M Flezar, GT Ferguson
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: Tiotropium + olodaterol (T+O) is a novel once-daily, fixed-dose combination of the long-acting muscarinic antagonist (LAMA) tiotropium (T) and the long-acting β2-agonist (LABA) olodaterol, for use as maintenance treatment in chronic obstructive pulmonary disease (COPD). These post hoc analyses of data from the two pivotal 1-year TONADO studies determined whether treatment with a long-acting bronchodilator…
Zitieren
Zitierempfehlung
T Greulich, R Buhl, R Abrahams, L Grönke, L Korducki, M Flezar, GT Ferguson (2016) Tiotropium Plus Olodaterol Fixed-Dose Combination Therapy Provides Lung Function Benefits When Compared With Tiotropium Alone, Irrespective Of Prior Treatment With A Long-Acting Bronchodilator: Post Hoc Analyses Of Two 1-Year-Studies. Pneumologie (02). https://doi.org/10.1055/s-0036-1572054
Mit CareLit weiterarbeiten